scholarly article | Q13442814 |
P50 | author | Torsten Haferlach | Q66370751 |
Tamara Alpermann | Q66370761 | ||
Ulrike Bacher | Q66370775 | ||
Claudia Haferlach | Q66370782 | ||
Susanne Schnittger | Q66370791 | ||
Frank Dicker | Q114293331 | ||
Vera Grossmann | Q114293334 | ||
Alexander Kohlmann | Q114293337 | ||
Christiane Eder | Q114293338 | ||
P2093 | author name string | Wolfgang Kern | |
P2860 | cites work | JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis | Q24609999 |
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders | Q29614510 | ||
Frequent pathway mutations of splicing machinery in myelodysplasia | Q29616088 | ||
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML) | Q30420638 | ||
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia | Q34770384 | ||
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. | Q35346433 | ||
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms | Q36270713 | ||
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis | Q36303447 | ||
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera | Q37112871 | ||
Genetic and epigenetic complexity in myeloproliferative neoplasms | Q37967274 | ||
Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms a paper from the 2010 William Beaumont hospital symposium on molecular pathology | Q42870230 | ||
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations | Q42931701 | ||
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms | Q47960630 | ||
LNK mutations in JAK2 mutation-negative erythrocytosis. | Q54649906 | ||
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1 | Q57740696 | ||
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance | Q58455666 | ||
An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders | Q72726990 | ||
Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E | Q80000872 | ||
Detection of an MPLW515 mutation in a case with features of both essential thrombocythemia and refractory anemia with ringed sideroblasts and thrombocytosis | Q80829715 | ||
P433 | issue | 10 | |
P921 | main subject | workflow | Q627335 |
myeloproliferative disorders | Q1898104 | ||
P304 | page(s) | 1582-1585 | |
P577 | publication date | 2012-04-17 | |
P1433 | published in | Haematologica | Q5638209 |
P1476 | title | Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow | |
P478 | volume | 97 |